HEALTHYWAY INC (02587) 2025 Annual Report Decoded: Demand and Capacity Resonance Leading the New Journey of the Medical Industry.

In 2025, the Chinese digital health and medical industry has entered a new stage of deep integration of intelligence and value medical care. HEALTHYWAY INC (02587) seized the opportunity of industry transformation, driven by strategic focus and technological innovation, and delivered a high-quality annual report. According to the financial report, in the 2025 fiscal year, HEALTHYWAY INC achieved operating income of 1.563 billion yuan, a year-on-year increase of 30.13%; and a net profit of 54.338 million yuan, successfully turning losses into profits. The unexpected financial report has attracted market attention. The high performance behind the high growth of Healthyway INC is obviously due to its precise targeting of the three major trends of digital transformation in the medical industry. First, Real-World Studies (RWS) are becoming the core decision-making basis for drug research and development and medical insurance access, and the industry's demand for high-value clinical data is growing explosively; second, under the dual pressures of increasing compliance and cost-saving, pharmaceutical companies are accelerating the transformation from traditional manpower marketing to precision digital models; thirdly, AI technology is deeply penetrating the medical scene, driving efficiency innovation throughout the entire chain from clinical research to commercialization. HEALTHYWAY INC closely followed the three major industry trends, clearly defining enterprise services and AI digital medical care as its core race track, achieving business growth and resonating with industry development. Looking at these three major strategic positions, the results are directly reflected in the strong growth of the enterprise services sector. In 2025, this sector achieved revenue of 1.356 billion yuan, a year-on-year increase of 42.6%. Leveraging the resources of 934,000 registered doctors and 12,870 cooperating hospitals as barriers, the company delivered 911 RWS reports for the whole year, a year-on-year increase of 39.5%, becoming the preferred supplier for many pharmaceutical companies. Next, HEALTHYWAY INC plans to accelerate its national ecological layout, deepen its localized operation through joint ventures with regional partners, further undertake the content services and digital transformation needs of pharmaceutical companies. AI business is another breakthrough for HEALTHYWAY INC in 2025. The AI digital employee generated revenue of over 32 million yuan in its first year, and the AI doctor assistant has been introduced into more than 20 medical institutions and selected as a typical case of artificial intelligence in Fujian province, marking the company's leap from technological research and development to commercial application. HEALTHYWAY INC stated that it will continue to increase investment in AI digital employees, accumulate high-quality end-user assets during deployment, and output deep-trained AI solutions to industry partners, opening up new sources of income. In 2026, HEALTHYWAY INC's AI technology is accelerating its external impact. According to the company's WeChat official account, in March, it has won the bids for the digital projects at Sichuan Provincial Orthopedic Hospital and Anji County People's Hospital, verifying the practicality and marketability of the technology. What is more noteworthy is the upgrade of HEALTHYWAY INC's cooperation with Anji County, extending from a single hospital to the entire county's health community, achieving a digital leap from "point" to "surface". Currently, there are over 18,000 county hospitals nationwide, and with the recognition of county-level health community solutions, related orders are expected to be concentrated in 2026. In terms of market space, the normalization of centralized procurement and the deepening of compliance requirements in the pharmaceutical industry are speeding up the transfer of traditional marketing budgets of 800 billion to 1 trillion yuan to digital channels. HEALTHYWAY INC stated that it will closely follow the trend of expanding the medical service market, strengthening connection with industry customers, and ensuring the continuous contribution of digital marketing services to stable cash flow. In summary, HEALTHYWAY INC has built a complete system of "resource barriers + technological leadership + ecological layout + project implementation". In the future, the company will focus on driving intelligence, developing ecology, and refining operations, deepen its nationwide enterprise service layout, and enhance the application of AI technology in multiple medical scenarios. Through the continuous resonance of demand and capability, it will promote efficiency innovation throughout the entire chain of the medical industry, achieving dual enhancement in scale and profitability.